Markets

TetraLogic prices relaunched IPO at $7

An image of a person holding up a graph
Credit: Shutterstock photo

TetraLogic Pharmaceuticals, which is developing small molecule therapeutics for the treatment of cancer, raised $50 million by offering 7.2 million shares at $7. TetraLogic Pharmaceuticals plans to list on the NASDAQ under the symbol TLOG. TetraLogic Pharmaceuticals initially filed confidentially on 9/16/2013. Oppenheimer & Co., Guggenheim Securities and Needham & Co. acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TLOG

Other Topics

IPOs

Latest Markets Videos